Total Payments
$16,231
2024 Payments
$2,061
Companies
68
Transactions
854
Medicare Patients
5,048
Medicare Billing
$409,240
Payment Breakdown by Category
Food & Beverage$16,194 (99.8%)
Education$36.87 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,194 | 849 | 99.8% |
| Education | $36.87 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,467 | 95 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,282 | 107 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $940.62 | 46 | $0 (2024) |
| ABBVIE INC. | $910.19 | 64 | $0 (2024) |
| Lilly USA, LLC | $822.83 | 61 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $814.51 | 56 | $0 (2022) |
| PFIZER INC. | $796.48 | 51 | $0 (2024) |
| Amgen Inc. | $606.58 | 29 | $0 (2024) |
| Novo Nordisk Inc | $579.09 | 28 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $543.37 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,061 | 107 | AstraZeneca Pharmaceuticals LP ($416.06) |
| 2023 | $2,167 | 114 | GlaxoSmithKline, LLC. ($306.28) |
| 2022 | $1,907 | 101 | GlaxoSmithKline, LLC. ($457.08) |
| 2021 | $2,297 | 99 | GlaxoSmithKline, LLC. ($482.99) |
| 2020 | $1,625 | 104 | AstraZeneca Pharmaceuticals LP ($347.85) |
| 2019 | $2,290 | 91 | GlaxoSmithKline, LLC. ($425.81) |
| 2018 | $1,853 | 117 | AstraZeneca Pharmaceuticals LP ($286.69) |
| 2017 | $2,031 | 121 | AstraZeneca Pharmaceuticals LP ($384.16) |
All Payment Transactions
854 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: PAIN | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $16.15 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/11/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: VACCINES | ||||||
| 12/03/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $19.12 | General |
| Category: Cranial Orthotic | ||||||
| 12/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Genetically Defined Disease | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: DIABETES | ||||||
| 11/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.93 | General |
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Hologic Sales and Service, LLC | THINPREP 2000 PROCESSOR (Device) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Diagnostics | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.56 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/31/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $19.95 | General |
| 10/25/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: VACCINES | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: PAIN | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.67 | General |
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,362 | 2,421 | $309,401 | $125,131 |
| 2022 | 17 | 1,318 | 2,433 | $279,940 | $105,257 |
| 2021 | 16 | 1,259 | 2,341 | $273,129 | $107,727 |
| 2020 | 16 | 1,109 | 1,972 | $215,011 | $71,125 |
Total Patients
5,048
Total Services
9,167
Medicare Billing
$409,240
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 432 | 873 | $134,484 | $51,207 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 213 | 432 | $97,632 | $38,594 | 39.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 34 | 34 | $18,700 | $9,604 | 51.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 59 | 59 | $14,573 | $7,835 | 53.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 90 | 90 | $7,395 | $6,747 | 91.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 101 | 101 | $6,060 | $3,197 | 52.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 32 | 35 | $7,000 | $1,760 | 25.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 70 | 161 | $7,084 | $1,642 | 23.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 56 | 56 | $2,240 | $1,080 | 48.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 55 | 55 | $2,145 | $1,060 | 49.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 28 | 28 | $1,664 | $886.20 | 53.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 74 | 79 | $2,844 | $673.24 | 23.7% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 13 | 13 | $845.00 | $435.37 | 51.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 46 | 58 | $1,160 | $197.78 | 17.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 40 | 256 | $5,120 | $178.15 | 3.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 19 | 91 | $455.00 | $35.06 | 7.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 420 | 879 | $135,438 | $51,512 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 180 | 322 | $72,772 | $27,970 | 38.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 56 | 56 | $13,832 | $7,620 | 55.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 77 | 77 | $11,060 | $5,265 | 47.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 69 | 79 | $15,800 | $4,020 | 25.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 96 | 96 | $5,760 | $2,936 | 51.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 76 | 155 | $6,820 | $1,628 | 23.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 57 | 57 | $2,280 | $1,122 | 49.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 46 | 46 | $1,794 | $887.87 | 49.5% |
About Dr. Ashokkumar Ghadia, M.D
Dr. Ashokkumar Ghadia, M.D is a Family Medicine healthcare provider based in Bakersfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124049234.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashokkumar Ghadia, M.D has received a total of $16,231 in payments from pharmaceutical and medical device companies, with $2,061 received in 2024. These payments were reported across 854 transactions from 68 companies. The most common payment nature is "Food and Beverage" ($16,194).
As a Medicare-enrolled provider, Ghadia has provided services to 5,048 Medicare beneficiaries, totaling 9,167 services with total Medicare billing of $409,240. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bakersfield, CA
- Active Since 07/22/2006
- Last Updated 12/03/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1124049234
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,470
- FARXIGA (Drug) $1,250
- NURTEC ODT (Drug) $834.37
- JARDIANCE (Drug) $833.61
- XARELTO (Drug) $642.10
- Vascepa (Drug) $508.90
- BREZTRI (Drug) $493.73
- JORNAY PM (Drug) $373.39
- UBRELVY (Drug) $350.17
- EMGALITY (Drug) $346.90
- TRINTELLIX (Drug) $313.44
- SHINGRIX (Biological) $284.72
- Kerendia (Drug) $254.81
- JANUVIA (Drug) $254.81
- Aimovig (Biological) $249.49
- Ozempic (Drug) $245.60
- LINZESS (Drug) $229.38
- MOUNJARO (Drug) $219.08
- EUCRISA (Drug) $200.92
- Trintellix (Drug) $198.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bakersfield
Mrs. Amira Ayad, M.d, M.D
Family Medicine — Payments: $278,616
Family Medicine $278,616
Matthew Beare, M.d, M.D
Family Medicine — Payments: $81,707
Family Medicine $81,707
Tien Nguyen, M.d, M.D
Family Medicine — Payments: $25,013
Family Medicine $25,013
Neha Chande, M.d., M.h.s, M.D., M.H.S
Family Medicine — Payments: $20,779
Family Medicine $20,779
John Heidrick, D.o, D.O
Family Medicine — Payments: $20,029
Family Medicine $20,029
Dr. Kamrun Naher, M.d, M.D
Family Medicine — Payments: $18,386
Family Medicine $18,386